Study reveals that over 93% of primary care patients expect antibiotics for common symptoms, especially in public clinics, with lack of education and health literacy contributing to these unrealistic expectations. Knowledge of antibiotic risks is a key factor influencing patient demand.
Clearmind Medicine and SciSparc to Conduct Study Evaluating Combination Treatment for Obesity and Metabolic Syndrome – Psychedelic Alpha
The treatment combines Clearmind’s MEAI, a novel proprietary psychedelic treatment for various addictions, and SciSparc’s Palmitoylethanolamide (PEA), the active ingredient of its proprietary CannAmide™ Tel
June 16, 2023